| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| CDKN2B-AS1 |
|
CDKN2B antisense RNA 1
|
|
|
0.491 |
0.769 |
| HNF1A-AS1 |
|
HNF1A antisense RNA 1
|
|
|
0.621 |
0.538 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
| HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
| COL11A2P1 |
|
collagen type XI alpha 2 pseudogene 1
|
|
|
0.805 |
0.462 |
| ADAMTS9-AS2 |
|
ADAMTS9 antisense RNA 2
|
|
|
0.656 |
0.462 |
| LINC01339 |
|
long intergenic non-protein coding RNA 1339
|
|
|
0.931 |
0.115 |
| MECOM-AS1 |
|
MECOM antisense RNA 1
|
|
|
0.931 |
0.077 |
| HLA-DPA3 |
|
major histocompatibility complex, class II, DP alpha 3 (pseudogene)
|
|
|
0.805 |
0.308 |
| TARID |
|
TCF21 antisense RNA inducing promoter demethylation
|
|
|
0.821 |
0.308 |
| UBE2Q2P1 |
|
ubiquitin conjugating enzyme E2 Q2 pseudogene 1
|
|
|
0.890 |
0.077 |
| DHFRP2 |
|
dihydrofolate reductase pseudogene 2
|
|
|
1.000 |
0.038 |
| ZSCAN16-AS1 |
|
ZSCAN16 antisense RNA 1
|
|
|
0.792 |
0.269 |
| LINC00240 |
|
long intergenic non-protein coding RNA 240
|
|
|
0.821 |
0.231 |
| LINC01016 |
|
long intergenic non-protein coding RNA 1016
|
|
|
0.839 |
0.154 |
| LINC02463 |
|
long intergenic non-protein coding RNA 2463
|
|
|
0.931 |
0.077 |
| HLA-V |
|
major histocompatibility complex, class I, V (pseudogene)
|
|
|
0.861 |
0.192 |
| SRRM4 |
A7MD48
|
serine/arginine repetitive matrix 4
|
|
0.46 |
0.736 |
0.231 |
| SLC17A3 |
O00476
|
solute carrier family 17 member 3
|
Transporter
|
4.9E-22 |
0.769 |
0.385 |
| BTN3A3 |
O00478
|
butyrophilin subfamily 3 member A3
|
Enzyme modulator
|
1.2E-18 |
0.792 |
0.308 |
| PLPP3 |
O14495
|
phospholipid phosphatase 3
|
Enzyme
|
0.92 |
0.722 |
0.192 |
| CUX2 |
O14529
|
cut like homeobox 2
|
Transcription factor
|
1.00 |
0.644 |
0.500 |